Malaria is a potentially serious parasitic infection transmitted through the bite of an infected mosquito. In humans the disease is caused by five different species of the Plasmodium parasite. Malaria is widely distributed throughout tropical regions of the world including in parts of Africa, Asia, Central and South America, the Caribbean, the Middle East and Oceania. Malaria is preventable and curable if diagnosed and treated promptly.

Around 1,500 cases of malaria are reported annually in travellers returning to or arriving in the UK, with eight or fewer deaths reported each year since 2006. The risk of malaria varies according to season, geographic location, activities, type of accommodation, and the use of malaria prevention tablets and bite avoidance measures. 

All travellers visiting areas where malaria occurs are at risk of acquiring the disease, particularly migrants to the UK who were born in malaria risk areas and return to visit friends and relatives in their country of birth. Any immunity travellers may have acquired in their country of origin wanes rapidly on migration to a country with no risk of malaria; their UK-born children will have no protection from the disease. Certain travellers are at increased risk of severe disease such as: pregnant women, those with an absent or poorly functioning spleen, children and older travellers.

Symptoms of malaria vary but typically include: fever, headache, fatigue, and muscle aches. Cough and diarrhoea may also occur. Malaria from all species can be disabling; however, malaria caused by the species Plasmodium falciparum can progress rapidly and cause life-threatening complications if prompt treatment is not given.


Prevention of malaria involves several steps. These steps can be remembered as the A, B, C, D of malaria prevention:

  • Awareness of the risk
  • Bite prevention (particularly at night time)
  • Chemoprophylaxis (use of appropriate malaria prevention tablets)
  • Diagnosis (prompt diagnosis and treatment)

Choice of malaria prevention tablets depends on the malaria species common in the area to be visited and whether there is resistance to any of the available drugs. Certain drugs may not be suitable for certain individuals owing to existing medical problems or interactions with their regular medication. 

All travellers should be aware of the signs and symptoms of malaria and should be advised to seek immediate medical attention if these occur either whilst abroad or up to a year after their return.



The National Travel Health Network and Centre (NaTHNaC) is commissioned by Public Health England to provide health information for both healthcare professionals and travellers. Information is compiled by the NaTHNaC clinical and scientific team, and updated regularly. Further advice on health risks and disease outbreaks is available at

Date last reviewed: November 2015

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.